Neoadjuvant (neo) immune checkpoint blockade (ICB) in patients (Pts) with high-risk resectable metastatic melanoma (MM).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Rodabe Navroze Amaria, Sangeetha Meda Reddy, Hussein Abdul-Hassan Tawbi, Michael A. Davies, Merrick I. Ross, Isabella Claudia Glitza, Janice N. Cormier, Carol M. Lewis, Wen-Jen Hwu, Ehab Y. Hanna, Adi Diab, Michael K.K. Wong, Richard Eldon Royal, Neil D. Gross, Randal S. Weber, Stephen Yenzen Lai, Richard A. Ehlers, Elizabeth M. Burton, Michael T. Tetzlaff, Jennifer Ann Wargo
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891804073